Insulin sensitivity is improved by metformin, which increases peripheral glucose uptake and utilization as well as decreases hepatic glucose production and intestinal glucose absorption; while symptoms like sulfonylureas, hyperinsulinemia or weight gain are not caused. The gene discussed is INS; the disease is hyperinsulinism.